Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.4 USD | -0.97% | +1.58% | -23.14% |
Summary
- The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
- The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.37 for the 2024 fiscal year.
- The company has a low valuation given the cash flows generated by its activity.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company sustains low margins.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Employment Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-23.14% | 609M | B+ | ||
-19.45% | 8.8B | A- | ||
-19.70% | 7.39B | A- | ||
-24.59% | 5.73B | B+ | ||
-4.13% | 3.73B | A- | ||
-10.33% | 3.16B | C+ | ||
+0.11% | 1.52B | - | ||
+10.49% | 1.5B | - | ||
-1.25% | 1.47B | - | ||
-5.27% | 1.2B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- CCRN Stock
- Ratings Cross Country Healthcare, Inc.